Analystreport

Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Crinetics Pharmaceuticals, Inc.  (CRNX) 
Last crinetics pharmaceuticals, inc. earnings: 3/9 04:10 pm Check Earnings Report